Showing results (431-440 of 1,758) with videos related to
Sort By:
Pageof 176
Journal of Parkinson'S Disease|August 9, 2021
Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous InfusionMatthew Rosebraugh, Wei Liu, Melina Neenan, et al.Journal of Parkinson'S Disease|June 16, 2020
Clinical Progression of Parkinson's Disease: Insights from the NINDS Common Data ElementsMechelle M Lewis, Elias Harkins, Eun-Young Lee, et al.Journal of Parkinson'S Disease|June 16, 2020
Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's DiseaseTony Werner, Istvan Horvath, Pernilla Wittung-StafshedeJournal of Parkinson'S Disease|August 21, 2022
Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic ConsiderationsLinh Thi Nhat Nguyen, Huu Dat Nguyen, Yun Joong Kim, et al.Journal of Parkinson'S Disease|November 22, 2021
Anticholinergic Medication Burden in Parkinson's Disease OutpatientsHuma Nawaz, Lana Sargent, Helengrace Quilon, et al.Journal of Parkinson'S Disease|November 22, 2021
Post-Illumination Pupil Response as a Biomarker for Cognition in α-SynucleinopathiesOliver Steiner, Jan de Zeeuw, Sophia Stotz, et al.Journal of Parkinson'S Disease|November 22, 2021
Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical SubtypesEmil Ygland Rödström, Niklas Mattsson-Carlgren, Shorena Janelidze, et al.Journal of Parkinson'S Disease|November 29, 2021
Determinants of Self-Stigma in People with Parkinson's Disease: A Mixed Methods Scoping ReviewAnne-Marie Hanff, Anja K Leist, Joëlle V Fritz, et al.Journal of Parkinson'S Disease|December 5, 2021
Biomarkers of Cerebral Glucose Metabolism and Neurodegeneration in Parkinson's Disease: A Cerebrospinal Fluid-Based StudyClaudio Liguori, Alessandro Stefani, Mariana Fernandes, et al.Journal of Parkinson'S Disease|September 4, 2022
Towards a Visualizable, De-identified Synthetic Biomarker of Human Movement DisordersHao Hu, Dongsheng Xiao, Helge Rhodin, et al.Pageof 176